183 related articles for article (PubMed ID: 10491432)
1. Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
Duska LR; Hamblin MR; Miller JL; Hasan T
J Natl Cancer Inst; 1999 Sep; 91(18):1557-63. PubMed ID: 10491432
[TBL] [Abstract][Full Text] [Related]
2. Photoimmunotherapy and ovarian cancer: an improbable fiction or a palpable hit?
Tochner ZA; Hahn S; Glatstein E
J Natl Cancer Inst; 1999 Sep; 91(18):1526-7. PubMed ID: 10491420
[No Abstract] [Full Text] [Related]
3. Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates.
Molpus KL; Hamblin MR; Rizvi I; Hasan T
Gynecol Oncol; 2000 Mar; 76(3):397-404. PubMed ID: 10684717
[TBL] [Abstract][Full Text] [Related]
4. Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model.
Goff BA; Hermanto U; Rumbaugh J; Blake J; Bamberg M; Hasan T
Br J Cancer; 1994 Sep; 70(3):474-80. PubMed ID: 8080733
[TBL] [Abstract][Full Text] [Related]
5. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging.
Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H
Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859
[TBL] [Abstract][Full Text] [Related]
6. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
[TBL] [Abstract][Full Text] [Related]
7. Photoimmunotherapy of human ovarian carcinoma cells ex vivo.
Goff BA; Bamberg M; Hasan T
Cancer Res; 1991 Sep; 51(18):4762-7. PubMed ID: 1716512
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
9. Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate.
Del Governatore M; Hamblin MR; Shea CR; Rizvi I; Molpus KG; Tanabe KK; Hasan T
Cancer Res; 2000 Aug; 60(15):4200-5. PubMed ID: 10945630
[TBL] [Abstract][Full Text] [Related]
10. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
[TBL] [Abstract][Full Text] [Related]
11. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo.
del Carmen MG; Rizvi I; Chang Y; Moor AC; Oliva E; Sherwood M; Pogue B; Hasan T
J Natl Cancer Inst; 2005 Oct; 97(20):1516-24. PubMed ID: 16234565
[TBL] [Abstract][Full Text] [Related]
12. Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.
Buchsbaum DJ; Zhou T; Grizzle WE; Oliver PG; Hammond CJ; Zhang S; Carpenter M; LoBuglio AF
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3731-41. PubMed ID: 14506165
[TBL] [Abstract][Full Text] [Related]
13. Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms.
Ito K; Mitsunaga M; Arihiro S; Saruta M; Matsuoka M; Kobayashi H; Tajiri H
BMC Cancer; 2016 Jan; 16():37. PubMed ID: 26810644
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of light emitting diodes (LEDs) and Lasers in near infrared photoimmunotherapy.
Sato K; Watanabe R; Hanaoka H; Nakajima T; Choyke PL; Kobayashi H
Oncotarget; 2016 Mar; 7(12):14324-35. PubMed ID: 26885688
[TBL] [Abstract][Full Text] [Related]
15. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
[TBL] [Abstract][Full Text] [Related]
16. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
Savellano MD; Pogue BW; Hoopes PJ; Vitetta ES; Paulsen KD
Cancer Res; 2005 Jul; 65(14):6371-9. PubMed ID: 16024640
[TBL] [Abstract][Full Text] [Related]
17. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.
Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257
[TBL] [Abstract][Full Text] [Related]
18. Photoimmunotherapy of gastric cancer peritoneal carcinomatosis in a mouse model.
Sato K; Choyke PL; Kobayashi H
PLoS One; 2014; 9(11):e113276. PubMed ID: 25401794
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
Uslu R; Bonavida B
Cancer; 1996 Feb; 77(4):725-32. PubMed ID: 8616765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]